These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36958694)

  • 1. m6A RNA methylation-mediated upregulation of HLF promotes intrahepatic cholangiocarcinoma progression by regulating the FZD4/β-catenin signaling pathway.
    Xiang D; Gu M; Liu J; Dong W; Yang Z; Wang K; Fu J; Wang H
    Cancer Lett; 2023 Apr; 560():216144. PubMed ID: 36958694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt/β-catenin signal pathway.
    Zhang H; Dong X; Ding X; Liu G; Yang F; Song Q; Sun H; Chen G; Li S; Li Y; Wang M; Guo T; Zhang Z; Li B; Yang L
    J Transl Med; 2023 Dec; 21(1):900. PubMed ID: 38082327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YBX1 promotes stemness and cisplatin insensitivity in intrahepatic cholangiocarcinoma via the AKT/β-catenin axis.
    Shi X; Hu Z; Bai S; Zong C; Xue H; Li Y; Li F; Chen L; Xuan J; Xia Y; Wei L; Shen F; Wang K
    J Gene Med; 2024 May; 26(5):e3689. PubMed ID: 38676365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LGR5 induces β-catenin activation and augments tumour progression by activating STAT3 in human intrahepatic cholangiocarcinoma.
    Kawasaki K; Kuboki S; Furukawa K; Takayashiki T; Takano S; Ohtsuka M
    Liver Int; 2021 Apr; 41(4):865-881. PubMed ID: 33249719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells' Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways.
    Wang J; Yu H; Dong W; Zhang C; Hu M; Ma W; Jiang X; Li H; Yang P; Xiang D
    Gastroenterology; 2023 May; 164(6):990-1005. PubMed ID: 36764493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VIRMA facilitates intrahepatic cholangiocarcinoma progression through epigenetic augmentation of TMED2 and PARD3B mRNA stabilization.
    Xu H; Lin X; Li Z; He X; Li Y; Qiu L; Lu L; Liu B; Zhan M; He K
    J Gastroenterol; 2023 Sep; 58(9):925-944. PubMed ID: 37391589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underexpression of LKB1 tumor suppressor is associated with enhanced Wnt signaling and malignant characteristics of human intrahepatic cholangiocarcinoma.
    Wang J; Zhang K; Wang J; Wu X; Liu X; Li B; Zhu Y; Yu Y; Cheng Q; Hu Z; Guo C; Hu S; Mu B; Tsai CH; Li J; Smith L; Yang L; Liu Q; Chu P; Chang V; Zhang B; Wu M; Jiang X; Yen Y
    Oncotarget; 2015 Aug; 6(22):18905-20. PubMed ID: 26056085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6-methyladenosine-modified circSLCO1B3 promotes intrahepatic cholangiocarcinoma progression via regulating HOXC8 and PD-L1.
    Li J; Xu X; Xu K; Zhou X; Wu K; Yao Y; Liu Z; Chen C; Wang L; Sun Z; Jiao D; Han X
    J Exp Clin Cancer Res; 2024 Apr; 43(1):119. PubMed ID: 38641828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin promotes metastasis of intrahepatic cholangiocarcinoma through recruiting MAPK1 and mediating Ser675 phosphorylation of β-Catenin.
    Zheng Y; Zhou C; Yu XX; Wu C; Jia HL; Gao XM; Yang JM; Wang CQ; Luo Q; Zhu Y; Zhang Y; Wei JW; Sheng YY; Dong QZ; Qin LX
    Cell Death Dis; 2018 Feb; 9(2):179. PubMed ID: 29415992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription.
    Chen Q; Wang H; Li Z; Li F; Liang L; Zou Y; Shen H; Li J; Xia Y; Cheng Z; Yang T; Wang K; Shen F
    J Hepatol; 2022 Jan; 76(1):135-147. PubMed ID: 34509526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-sensing receptor promotes tumor proliferation and migration in human intrahepatic cholangiocarcinoma by targeting ERK signaling pathway.
    Fang Y; Liu L; Liu S; Hu L; Cai W; Wan X; Liu D; He Y; Zhu Z
    Eur J Pharmacol; 2020 Apr; 872():172915. PubMed ID: 31926993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting PKM2 improves the gemcitabine sensitivity of intrahepatic cholangiocarcinoma cells via inhibiting β-catenin signaling pathway.
    Yu W; Zeng F; Xiao Y; Chen L; Qu H; Hong J; Qu C; Cheng G
    Chem Biol Interact; 2024 Jan; 387():110816. PubMed ID: 38000456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy.
    Gao J; Fang Y; Chen J; Tang Z; Tian M; Jiang X; Tao C; Huang R; Zhu G; Qu W; Wu X; Zhou J; Fan J; Liu W; Shi Y
    Oncogene; 2023 Aug; 42(33):2507-2520. PubMed ID: 37420030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m
    Xu QC; Tien YC; Shi YH; Chen S; Zhu YQ; Huang XT; Huang CS; Zhao W; Yin XY
    Oncogene; 2022 Mar; 41(11):1622-1633. PubMed ID: 35094011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SQSTM1/p62 in intrahepatic cholangiocarcinoma promotes tumor progression via epithelial-mesenchymal transition and mitochondrial function maintenance.
    Chen J; Gao Z; Li X; Shi Y; Tang Z; Liu W; Zhang X; Huang A; Luo X; Gao Q; Ding G; Song K; Zhou J; Fan J; Fu X; Ding Z
    Cancer Med; 2023 Jan; 12(1):459-471. PubMed ID: 35676831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt/β-catenin signaling as an emerging potential key pharmacological target in cholangiocarcinoma.
    Zhang GF; Qiu L; Yang SL; Wu JC; Liu TJ
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32140709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of TTYH3 promotes epithelial-to-mesenchymal transition through Wnt/β-catenin signaling and inhibits apoptosis in cholangiocarcinoma.
    Xue W; Dong B; Zhao Y; Wang Y; Yang C; Xie Y; Niu Z; Zhu C
    Cell Oncol (Dordr); 2021 Dec; 44(6):1351-1361. PubMed ID: 34796468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling.
    Tang J; Liao Y; He S; Shi J; Peng L; Xu X; Xie F; Diao N; Huang J; Xie Q; Lin C; Luo X; Liao K; Ma J; Li J; Zhou D; Li Z; Xu J; Zhong C; Wang G; Bai L
    J Transl Med; 2017 Nov; 15(1):238. PubMed ID: 29178939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-552 promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma by targeting FOXO1.
    Cheng Z; Cheng N; Tang X; Yang F; Ma W; Yu Q; Tang H; Xiao Q; Lei Z
    Exp Cell Res; 2023 Oct; 431(1):113741. PubMed ID: 37549804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YTHDF1 promotes intrahepatic cholangiocarcinoma progression via regulating EGFR mRNA translation.
    Huang X; Zhu L; Wang L; Huang W; Tan L; Liu H; Huo J; Su T; Zhang M; Kuang M; Li X; Dai Z; Xu L
    J Gastroenterol Hepatol; 2022 Jun; 37(6):1156-1168. PubMed ID: 35233828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.